According to studies, semaglutide through GLP-1 enhances adipose tissue browning and the formation of new adipocytes and ameliorates dysfunctional adiposity in obesity [48]. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.